Bullfrog AI Holdings (Bullfrog AI Holdings) Change In Receivables : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Change In Receivables?

Bullfrog AI Holdings's change in receivables for the quarter that ended in Mar. 2024 was $0.00 Mil. It means Bullfrog AI Holdings's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Bullfrog AI Holdings's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Bullfrog AI Holdings's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Bullfrog AI Holdings's Accounts Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bullfrog AI Holdings's liquidation value for the three months ended in Mar. 2024 was $6.17 Mil.

Bullfrog AI Holdings Change In Receivables Historical Data

The historical data trend for Bullfrog AI Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Change In Receivables Chart

Bullfrog AI Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Bullfrog AI Holdings Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial								-	-	-	-	-

Bullfrog AI Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Bullfrog AI Holdings (NAS:BFRG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bullfrog AI Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Bullfrog AI Holdings's accounts receivable are only considered to be worth 75% of book value:

Bullfrog AI Holdings's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	7.011	-	0.845	+	0.75 * 0	+	0.5 * 0
=	6.17

Bullfrog AI Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878

Website

https://www.bullfrogai.com

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Executives

William Enright	director	910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio	officer: Chief Financial Officer
Jason David Hanson	director	8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh	director, 10 percent owner, officer: Chief Executive Officer	4 BLACK KETTLE COURT, BOYDS MD 20841